195 related articles for article (PubMed ID: 32970275)
1. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
Fujimoto S; Kawabata H; Sakai T; Yanagisawa H; Nishikori M; Nara K; Ohara S; Tsukamoto N; Kurose N; Yamada S; Takai K; Aoki S; Masaki Y
Int J Hematol; 2021 Jan; 113(1):73-80. PubMed ID: 32970275
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review.
Akiyama M; Kaneko Y; Takeuchi T
Ann Hematol; 2020 Nov; 99(11):2463-2475. PubMed ID: 32964342
[TBL] [Abstract][Full Text] [Related]
5. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
6. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
Wakiya R; Kameda T; Takeuchi Y; Ozaki H; Nakashima S; Shimada H; Kadowaki N; Dobashi H
Mod Rheumatol Case Rep; 2021 Jan; 5(1):145-151. PubMed ID: 33269653
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
[TBL] [Abstract][Full Text] [Related]
8. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
11. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.
Aoki T; Wada M; Kawashima A; Hirakawa K; Nagata A; Kagawa K
Intern Med; 2017 Dec; 56(23):3249-3254. PubMed ID: 29021431
[TBL] [Abstract][Full Text] [Related]
13. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
[TBL] [Abstract][Full Text] [Related]
14. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
[TBL] [Abstract][Full Text] [Related]
15. Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.
Ohya E; Mizutani M; Sakaguchi H; Sekine T
Intern Med; 2016; 55(19):2861-2867. PubMed ID: 27725549
[TBL] [Abstract][Full Text] [Related]
16. Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
Yamaguchi Y; Maeda Y; Shibahara T; Nameki S; Nakabayashi A; Komuta K; Mizuno Y; Yagita M; Manabe Y; Morita T; Nishide M; Watanabe A; Takamatsu H; Nishida S; Hirano T; Shima Y; Narazaki M; Kumanogoh A
Mod Rheumatol Case Rep; 2020 Jul; 4(2):302-309. PubMed ID: 33087016
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
18. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
19. [TAFRO syndrome and cutaneous necrotizing vasculitis].
Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
[TBL] [Abstract][Full Text] [Related]
20. [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
Sumi C; Toki Y; Funayama T; Saito T; Hatayama M; Yamamoto M; Shindo M; Yuzawa S; Tanino M; Okumura T
Rinsho Ketsueki; 2023; 64(4):265-270. PubMed ID: 37121770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]